Dr. Donald O’Keefe appointed Global Scientific Leader for Eurofins Bioanalytical Services
Saint Charles, MO – June 1, 2018
Eurofins Bioanalytical Services, a leading provider of biologics-focused bioanalytical solutions announced the addition of Dr. Donald O’Keefe to its leadership team as Global Scientific Leader. Dr. O’Keefe has an extensive background working with pharmaceutical and biotechnology organizations in large molecule drug development spanning over 25 years.
Dr. O’Keefe works closely to drive new technology and overall strategy for growth providing solutions for large molecule bioanalysis clients. He serves as a single point of contact for client development programs with a focus on expanding large molecule capabilities as well as provides strategic scientific oversight of study designs. He is the scientific and technical advisor for clients and internal teams for development, validation, and application of assays to ensure compliance with regulatory requirements.
"Don’s proven scientific leadership experience is a great addition for Eurofins Bioanalytical Services and our clients" said Christina Shasserre, Senior Vice President, Eurofins Pharma Discovery and Bioanalytics Services. "He brings a unique set of experiences that will enhance understanding of our clients' needs so we can continue to build strong relationships with our clients focusing on performance and transparency".
During Dr. O’Keefe’s distinguished scientific career, he has held positions of increasing responsibility within the biopharmaceutical industry. After receiving his PhD from The University of Texas at Dallas, Dr. O’Keefe became an NIH research fellow at Harvard Medical School. An accomplished leader in the field of bioanalysis and large molecule drug development, he has been involved in various industry organizations, including AAAS, AAPS and ASCB and is an invited speaker at multiple industry events.
For more information, please contact us
About Eurofins Pharma Bioanalytical Services- Biologics Done Right
Eurofins Bioanalytical Services is a biologics-focused, global leader in bioanalytical solutions providing over 15 years of industry-leading scientific expertise.
At our state-of-the-art testing facilities in Oxford, UK and St. Charles, USA we develop, transfer and validate large molecule PK/TK, ADA, Nab and biomarker assays and sample analysis to our client’s specifications as well as offer a comprehensive listing of pre-qualified assays spanning decades of experience. With industry-leading capacity, we support studies ranging from preclinical non-GLP to IND enabling Tox studies to multi-national Phase III clinical trials. We can take your biologic drug from research through development to FDA regulatory submission.